VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 424 filers reported holding VANECK VECTORS ETF TR in Q4 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $9,601,100 | +341.6% | 335,000 | +353.9% | 0.29% | +163.1% |
Q3 2021 | $2,174,000 | -74.4% | 73,800 | -70.5% | 0.11% | -75.1% |
Q2 2021 | $8,495,000 | +30.7% | 250,000 | +25.0% | 0.44% | +54.0% |
Q1 2021 | $6,500,000 | +0.3% | 200,000 | +11.1% | 0.29% | +21.4% |
Q4 2020 | $6,483,000 | -45.6% | 180,000 | -44.6% | 0.24% | -58.5% |
Q2 2020 | $11,915,000 | +113.8% | 324,852 | +34.3% | 0.57% | +45.8% |
Q1 2020 | $5,572,000 | +895.0% | 241,852 | +867.4% | 0.39% | +1210.0% |
Q1 2019 | $560,000 | -73.7% | 25,000 | -78.3% | 0.03% | -31.8% |
Q3 2018 | $2,129,000 | -77.8% | 115,000 | -73.3% | 0.04% | -87.7% |
Q2 2018 | $9,593,000 | -70.9% | 430,000 | -71.3% | 0.36% | -59.5% |
Q1 2018 | $32,970,000 | +72.2% | 1,500,000 | +82.1% | 0.88% | +76.6% |
Q4 2017 | $19,142,000 | -45.9% | 823,661 | -46.6% | 0.50% | -32.8% |
Q3 2017 | $35,387,000 | +146.6% | 1,541,258 | +137.1% | 0.74% | +97.6% |
Q2 2017 | $14,352,000 | +529.2% | 650,000 | +550.0% | 0.38% | +317.8% |
Q1 2017 | $2,281,000 | -96.7% | 100,000 | -96.2% | 0.09% | -95.9% |
Q3 2016 | $68,718,000 | +404.1% | 2,600,000 | +428.3% | 2.21% | +215.1% |
Q2 2016 | $13,631,000 | – | 492,100 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $20,220,000 | 66.82% |
Baymount Management LP | 145,000 | $3,970,000 | 28.08% |
New Harbor Financial Group, LLC | 1,371,341 | $37,547,000 | 18.51% |
New Harbor Financial Group, LLC | 1,291,700 | $35,366,000 | 17.44% |
MKP Capital Management, L.L.C. | 1,500,000 | $41,070,000 | 13.74% |
Windmill Hill Asset Management Ltd | 844,600 | $23,125,000 | 11.94% |
Hollow Brook Wealth Management LLC | 768,567 | $21,043,000 | 11.57% |
Grand Central Investment Group | 261,915 | $7,171,000 | 10.33% |
Point72 Europe (London) LLP | 1,467,000 | $40,166,000 | 8.50% |
Slate Path Capital LP | 4,600,000 | $125,948,000 | 7.87% |